Nuveen Asset Management »

Protalix Biotherapeutics shares owned by Nuveen Asset Management

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Nuveen Asset Management from 13F filings

Historical chart of Nuveen Asset Management investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by Nuveen Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by Nuveen Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $343k 272k 1.26
2023-09-30 $435k 262k 1.66
2023-06-30 $524k 262k 2.00

More positions owned by Nuveen Asset Management

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
Eli Lilly & Co. (LLY)
Mastercard Incorporated Cl A (MA)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Nush Etf Tr Get Opp Etf (NUGO)
Linde SHS (LIN)

View all positions for Nuveen Asset Management

Top funds holding Protalix Biotherapeutics

BlackRock
Geode Capital Management
GSA Capital Partners
Northern Trust
Vanguard Group
Nuveen Asset Management
Bridgeway Capital Management
Bank of New York Mellon
Morgan Stanley
Virtu Financial
Charles Schwab Investment Management
Bank of America Corporation
Susquehanna International
Goldman Sachs Group
Two Sigma Securities

View all funds holding Protalix Biotherapeutics